Вот и рассуждения на эту увлекательную тему - https://www.sciencenews.org/blog/scicurious/addiction-showcases-brain-flexibility
06.08.2014
Алкоголизм, наркомания, порнозависимость - а с мозгом что?
Вот и рассуждения на эту увлекательную тему - https://www.sciencenews.org/blog/scicurious/addiction-showcases-brain-flexibility
26.07.2012
Опять результаты исследований эффектов экстази
Though ecstasy is known to cause health risks such as depression, sleep problems, severe anxiety and increasing other drug cravings, there has been a considerable amount of debate questioning whether or not government officials have over-reacted to ecstasy.
24.12.2011
08.05.2011
Допаминово-серотониновые новости :)
Neuropharmacology. 2011 Apr 12.
Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: Implications for schizophrenia.
van den Buuse M, Ruimschotel E, Martin S, Risbrough VB, Halberstadt AL.
Behavioural Neuroscience Laboratory, Mental Health Research Institute, Parkville, Melbourne, Australia; Department of Pharmacology, University of Melbourne, Australia.
Neuropharmacology. 2011 Apr 15.
Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system.
Murotani T, Ishizuka T, Isogawa Y, Karashima M, Yamatodani A.
Department of Medical Science and Technology, Division of Health Sciences, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka 565-0871, Japan.
Neuropharmacology. 2011 Apr 17.
Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.
Gould RW, Gage HD, Banks ML, Blaylock BL, Czoty PW, Nader MA.
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, United States.
Neuropharmacology. 2011 Apr 19.
Dopamine-related drugs act presynaptically to potentiate GABA(A) receptor currents in VTA dopamine neurons.
Michaeli A, Yaka R.
Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Neuropharmacology. 2011 Apr 7.
High concentrations of MDMA ('ecstasy') and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells.
Hondebrink L, Meulenbelt J, Meijer M, van den Berg M, Westerink RH.
Neurotoxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands; National Poisons Information Centre (NVIC), National Institute for Public Health and the Environment (RIVM), P.O. Box 1, NL-3720 BA, Bilthoven, The Netherlands.
26.07.2010
Экстази как лекарство
Два хороших поста о клинических испытаниях использования МДМА в качестве лекарства при посттравматическом синдроме. Очень совеитую почитать:
The media coverage of the MDMA Clinical trial result stinks
MDMA for PTSD: The first peer-reviewed clinical trial report
25.05.2009
Новое о механизмах эффектов экстази
Очень интересно... Как всегда грамотно написано на http://scienceblogs.com/drugmonkey/2009/05/waitcannabis_potentiates_the_e.php
Wait...Cannabis potentiates the effects of Ecstasy?
Category: Cannabis • MDMA
Posted on: May 15, 2009 5:35 PM, by DrugMonkey
Along with alcohol, caffeine and nicotine, the most-active ingredient in cannabis (Δ9-THC; "THC") is frequently co-ingested with MDMA by the Ecstasy user. There are, in fact, some suggestions that cannabis may be consumed in some cases specifically to assist with modulating the MDMA high.
Now, those that are aware of the tetrad test for cannabinoid action (necessary back before the first cannabinoid receptor was cloned in the early 90s) might think to themselves of a specific protective effect. One of the hallmarks of THC is that it reduces body temperature in rats. So if one of the problems with MDMA is that it results in high body temperature, it might be convenient if smoking a little dope had an action that reversed this physiological outcome.
This was supported by a paper by Morley et al (2004) which reported that yes indeed, if you inject a rat with 2.5 mg/kg THC i.p. it completely blocks the tympanic temperature elevation produced by 5 mg/kg MDMA i.p.
A recent study in humans suggests that caution is warranted.
Cannabis Coadministration Potentiates the Effects of "Ecstasy" on Heart Rate and Temperature in Humans. Dumont G, Kramers C, Sweep F, Touw D, van Hasselt J, de Kam M, van Gerven J, Buitelaar J, Verkes R. Clin Pharmacol Ther. 2009 May 13.
This study reports on the effects of 100 mg oral MDMA, three inhalations of about 6 mg THC (spaced at 90 min) and the combination in 13 human subjects. Plasma kinetics for the exogenous drugs, for norepinephrine and epinephrine and heart rate are reported. One of the more interesting bits, however, is reported in the following figure.
Tympanic temperature was increased by oral consumption of MDMA, reaching a peak about 90 minutes after ingestion (consistent with the plasma peak), as one might expect*. inhaling vaporized THC did not block this effect. The first inhalation of THC (timed to pill ingestion) looks to have delayed the onset of the temperature increase. However the second inhalation did not induce further delay and temperature ultimately reached a peak change approximately equal to the one after MDMA alone. The elevated temperature was sustained up to the end of the 300 min observation interval in the THC-MDMA combined condition compared with MDMA alone.
Hmm. Looking for differences here. The biggest thing would seem to be that this level of THC inhalation did not produce a reduction in body temperature by itself in humans. The doses that decrease body temperature in rodents are fairly high ones so what were these humans receiving? Well, the inhalation procedure in this study resulted in plasma levels of 60-80 ng/ml. This NHTSA site claims that 100-200 ng/ml of THC are "routinely" observed in cannabis smokers. See this, this, this for confirmation. So the present study was perhaps on the low side of things, but then speculating exactly how much cannabis an Ecstasy user might smoke is.....well, speculative. And the study did report about a 20-30 bpm elevation in heart rate after THC inhalation that appeared to be independent of MDMA (which itself elevated heart rate by about 20-30 bpm). So it was certainly in the range of physiological relevance.
Give that this study is in humans, given the doses seem more in line with what would be expected in the user population, I'd have to put more confidence in this study than in the Morley et al (2004) rat paper. Thus it appears unlikely that cannabis smoking in the recreational Ecstasy user provides any protection against MDMA-induced hyperthermia.
The prolongation of the elevated body temperature that was the excuse for using "Potentiates" in the title? Doesn't support a strong conclusion at this stage but it certainly brings up some other scenarios for risk with subsequent dosing.
__
*Actually it is not entirely true that one might expect this. This is well below the doses used in the clinical trials. One of the initial results seems to imply not just that mean temp did not significantly increase but that no individual experienced a 1 deg Celsius increase in temperature. Liechti and Vollenweider (2000) reported no effect of 1.5 mg/kg oral MDMA on axillary temperature. Nevertheless in a dedicated experiment using an ingested remote device to measure gastric ("core") temperature Freedman and colleagues (2005) found that 2 mg/kg oral MDMA did increase body temperature under cool and warm laboratory conditions.

